Search results
Barinthus lays off 25% of staff, sidelines prostate cancer program to stretch out cash
FierceBiotech· 6 days agoBarinthus Biotherapeutics has used positive interim data from a pair of phase 2 trials for its ...
Barinthus Bio slashes headcount by 25% and refocuses pipeline
Clinical Trials Arena via Yahoo Finance· 5 days agoThe UK-based T cell specialist – formerly known as Vaccitech – said it will prioritise its pipeline...
Live from EHA 2024 | Posters Featuring Results from Three Studies of Olverembatinib, Including...
FOX 23 News Albany· 22 hours agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related ...
Washington aims to eradicate hepatitis C, and screening matters
Gannett via AOL· 4 days agoIt was named hepatitis A. The second spread by contaminated blood and bodily fluids. It took longer...
Kate Middleton makes 1st public appearance in 6 months at Trooping the Colour amid cancer...
Yahoo Canada Style· 3 days agoAccording to the American Cancer Society, symptoms can include weight loss, upper abdominal pain and...
Free Sumner health expo with screenings for all, door prizes, lunch, more set for June
Gannett via AOL· 2 days agoWalgreens Pharmacy in Gallatin will provide vaccines for COVID, Shingles, RSV, Pneumococcal and Hepatitis B, Woods said. Proof of insurance is required.
Gilead's New Revelation For Its Weight-Loss Contender
Investor's Business Daily· 1 day agoOn Friday, shares of Gilead Sciences (GILD) shot up 2.4% after a poster published ahead of the...
Indaptus Therapeutics, Inc. (NASDAQ:INDP) Sees Significant Decline in Short Interest
ETF DAILY NEWS· 22 hours agoIndaptus Therapeutics, Inc. (NASDAQ:INDP – Get Free Report) was the target of a large drop in short interest in May. As of May 31st, there was short interest totalling 15,600 shares, a drop ...
Post-viral arthritis: Causes, symptoms, and treatments
Medical News Today· 5 days agoViral arthritis is an uncommon form of arthritis that occurs following a viral infection. It can...
GSK signs AI pact with Ochre to pinpoint source of liver diseases
FierceBiotech· 7 days agoGSK and Ochre Bio will work together in a $37.5 million partnership to pinpoint the drivers of liver disease. The new partnership, announced Wednesday morning, will see GSK access Ochre’s computational ...